0
0
0
Increasing Transparency in Generic Drug Applications Act
12/15/2023, 4:06 PM
Current Status of Bill S 775
Bill S 775 is currently in the status of Bill Introduced since March 14, 2023. Bill S 775 was introduced during Congress 118 and was introduced to the Senate on March 14, 2023. Bill S 775's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 14, 2023
Bipartisan Support of Bill S 775
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 775
Primary Policy Focus
HealthComments
Sponsors and Cosponsors of S 775
Latest Bills
National Defense Authorization Act for Fiscal Year 2026
Bill S 1071December 13, 2025
Enduring Justice for Victims of Trafficking Act
Bill S 2584December 13, 2025
Technical Corrections to the Northwestern New Mexico Rural Water Projects Act, Taos Pueblo Indian Water Rights Settlement Act, and Aamodt Litigation Settlement Act
Bill S 640December 13, 2025
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Bill HR 3383December 13, 2025
BOWOW Act of 2025
Bill HR 4638December 13, 2025
Northern Mariana Islands Small Business Access Act
Bill HR 3496December 13, 2025
Wildfire Risk Evaluation Act
Bill HR 3924December 13, 2025
Energy Choice Act
Bill HR 3699December 13, 2025
ESTUARIES Act
Bill HR 3962December 13, 2025
Improving Interagency Coordination for Pipeline Reviews Act
Bill HR 3668December 13, 2025
Expanding Access to Low-Cost Generics Act of 2023
Bill S 1114February 6, 2024
Lower Costs, More Transparency Act
Bill HR 5378February 6, 2024
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Bill HR 3839February 5, 2024
